Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

An Insider Just Bought Hedge Fund Darling Mead Johnson Nutrition CO (MJN)

According to a filing with the SEC, an LLC connected to Mead Johnson Nutrition CO (NYSE:MJN) Board member Howard Bernick purchased a little over 3,500 shares of the company’s stock on April 30th at an average price of $82.38 per share. Insiders should be reluctant to buy shares of their company, instead preferring to diversify- unless they are more confident in the stock’s prospects than the usual “this will be a good year for us.” In fact, studies do show a small outperformance effect for stocks bought by insiders (read our analysis of studies on insider trading) and so we think that insider purchases can work similarly to a stock screen as a source of investment ideas. Bernick also has a decent personal track record of buying Mead Johnson Nutrition CO (NYSE:MJN): our database has him making a purchase a little over four years ago at $24 per share.

Mead Johnson Nutrition CO (NYSE:MJN) sells infant formula and other children’s nutrition products, including products for children with special dietary needs. The company reported 5% revenue growth in the first quarter of 2013 versus a year earlier; due to higher costs- notably, a significant increase in advertising and promotion expenses- net income grew by 3%. Considering that the market is granting Mead Johnson a premium valuation on the strength of its business, these results are somewhat disappointing in our view. The market capitalization of over $16 billion places the food company at 27 times trailing earnings; even in an industry where valuations have been bid up following Berkshire Hathaway’s purchase of Heinz, that seems high to us.


Several hedge funds were aggressively buying Mead Johnson Nutrition CO (NYSE:MJN) during the fourth quarter of 2012, according to our database of 13F filings which we track as part of our work developing investment strategies (we have found, for example, that the most popular small cap stocks among hedge funds generate an average excess return of 18 percentage points per year). For example, billionaire and Tiger Cub Stephen Mandel’s Lone Pine Capital initiated a position of 3.7 million shares during the quarter (see Mandel’s stock picks). Other buyers of Mead Johnson included Citadel Investment Group and Bain Capital’s hedge fund Brookside Capital.

Other large cap food companies include General Mills, Inc. (NYSE:GIS), Kellogg Company (NYSE:K), Campbell Soup Company (NYSE:CPB), and The J.M. Smucker Company (NYSE:SJM). Kellogg and J.M. Smucker are also valued at over 20 times their trailing earnings, though they are still valued at at least something of a discount to Mead Johnson Nutrition CO (NYSE:MJN). The J.M. Smucker Company (NYSE:SJM)’s earnings were up strongly in its most recent quarter compared to the same period in the previous fiscal year, but revenue was only up 6%. We’re not sure the improvements on its bottom line are sustainable, so we would avoid the stock at its current pricing.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.